Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

25 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Expression and clinical relevance of NY-ESO-1, MAGE-1 and MAGE-3 in neuroblastoma.
Söling A, Schurr P, Berthold F. Söling A, et al. Anticancer Res. 1999 May-Jun;19(3B):2205-9. Anticancer Res. 1999. PMID: 10472332
Autoantibodies to the inhibitor of apoptosis protein survivin in patients with brain tumors.
Söling A, Plugge EM, Schmitz M, Weigle B, Jacob R, Illert J, Holzhausen HJ, Rainov NG. Söling A, et al. Int J Oncol. 2007 Jan;30(1):123-8. Int J Oncol. 2007. PMID: 17143520
Minichromosome maintenance protein 3 elicits a cancer-restricted immune response in patients with brain malignancies and is a strong independent predictor of survival in patients with anaplastic astrocytoma.
Söling A, Sackewitz M, Volkmar M, Schaarschmidt D, Jacob R, Holzhausen HJ, Rainov NG. Söling A, et al. Clin Cancer Res. 2005 Jan 1;11(1):249-58. Clin Cancer Res. 2005. PMID: 15671553
EXPERIMENTAL DESIGN: Tumor-associated antigens were identified by immunoscreening of a human glioma cDNA expression library with allogeneic sera from patients with diffuse astrocytoma (WHO grades 2-4). ...CONCLUSIONS: MCM3 may represent a glioma-associated antigen w …
EXPERIMENTAL DESIGN: Tumor-associated antigens were identified by immunoscreening of a human glioma cDNA expression library with allo …
Dendritic cell therapy of primary brain tumors.
Soling A, Rainov NG. Soling A, et al. Mol Med. 2001 Oct;7(10):659-67. Mol Med. 2001. PMID: 11713365 Free PMC article. Review.
A dual function fusion protein of Herpes simplex virus type 1 thymidine kinase and firefly luciferase for noninvasive in vivo imaging of gene therapy in malignant glioma.
Söling A, Theiss C, Jungmichel S, Rainov NG. Söling A, et al. Genet Vaccines Ther. 2004 Aug 4;2(1):7. doi: 10.1186/1479-0556-2-7. Genet Vaccines Ther. 2004. PMID: 15294018 Free PMC article.
Therefore, this study aimed at developing a strategy for real-time noninvasive in vivo monitoring of the activity of a therapeutic gene in brain tumor cells. ...CONCLUSION: This approach may represent a valuable tool for the in vivo evaluation of gene therapy …
Therefore, this study aimed at developing a strategy for real-time noninvasive in vivo monitoring of the activity of a therape …
Osteopontin and splice variant expression level in human malignant glioma: radiobiologic effects and prognosis after radiotherapy.
Güttler A, Giebler M, Cuno P, Wichmann H, Keßler J, Ostheimer C, Söling A, Strauss C, Illert J, Kappler M, Vordermark D, Bache M. Güttler A, et al. Among authors: soling a. Radiother Oncol. 2013 Sep;108(3):535-40. doi: 10.1016/j.radonc.2013.06.036. Epub 2013 Jul 25. Radiother Oncol. 2013. PMID: 23891093
Bioluminescence imaging to monitor bladder cancer cell adhesion in vivo: a new approach to optimize a syngeneic, orthotopic, murine bladder cancer model.
Jurczok A, Fornara P, Söling A. Jurczok A, et al. Among authors: soling a. BJU Int. 2008 Jan;101(1):120-4. doi: 10.1111/j.1464-410X.2007.07193.x. Epub 2007 Sep 20. BJU Int. 2008. PMID: 17888045 Free article.
Tumor-specific activity of cellular regulatory elements is down-regulated upon insertion into the herpes simplex virus genome.
Glass M, Söling A, Messerle M. Glass M, et al. Among authors: soling a. J Neurovirol. 2008 Nov;14(6):522-35. doi: 10.1080/13550280802348214. J Neurovirol. 2008. PMID: 18979278
mRNA expression levels of hypoxia-induced and stem cell-associated genes in human glioblastoma.
Bache M, Rot S, Keßler J, Güttler A, Wichmann H, Greither T, Wach S, Taubert H, Söling A, Bilkenroth U, Kappler M, Vordermark D. Bache M, et al. Among authors: soling a. Oncol Rep. 2015 Jun;33(6):3155-61. doi: 10.3892/or.2015.3932. Epub 2015 Apr 27. Oncol Rep. 2015. PMID: 25963717
Combined effects of temozolomide and the ribonucleotide reductase inhibitors didox and trimidox in malignant brain tumor cells.
Figul M, Söling A, Dong HJ, Chou TC, Rainov NG. Figul M, et al. Among authors: soling a. Cancer Chemother Pharmacol. 2003 Jul;52(1):41-6. doi: 10.1007/s00280-003-0611-2. Epub 2003 Apr 11. Cancer Chemother Pharmacol. 2003. PMID: 12690517
Ribonucleotide reductase (RR), the rate-limiting enzyme of DNA synthesis, seems to be a complementary target for combination chemotherapy of brain tumors. ...Depending on the combination ratio, the doses for each drug for a given degree of effect in the combination …
Ribonucleotide reductase (RR), the rate-limiting enzyme of DNA synthesis, seems to be a complementary target for combination chemothe …
25 results
Jump to page
Feedback